Chargement en cours...
Prescribers’ perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
BACKGROUND: There is an acknowledged lack of robust and rigorous research focusing on the perspectives of those prescribing direct acting oral anticoagulants (DOACs) for non-valvular atrial fibrillation (AF). OBJECTIVE: The objective was to describe prescribers’ experiences of using DOACs in the man...
Enregistré dans:
| Publié dans: | Pharm Pract (Granada) |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7308911/ https://ncbi.nlm.nih.gov/pubmed/32587643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18549/PharmPract.2020.2.1936 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|